Here are some of the top life sciences news stories and tweets from the week (April 7-11, 2014). First phase I clinical data shows NGM Biopharmaceuticals’ biliary cirrhosis drug NGM-282 is safe and well tolerated. Live from #ILC2014 — Cortellis (@Cortellis) April 10, 2014 MT @Reuters_Health: @bmsnews Bristol-Myers hepatitis C treatment cures up to 90 […]
written on 11.04.2014
Top Life Sciences News Stories Vol. 42
